Low Seroprevalence among Undetected COVID-19 Cases,Faroe Islands,November 2020 |
| |
| Authors: | Maria Skaalum Petersen,Marin Strø m,Jó gvan Pá ll Fjallsbak,Jó hanna Ljó sá Hansen,Só lrun Larsen,Eina H. Eliasen,Malan Johansen,Anna Sofí a Veyhe,Marnar Frí ð heim Kristiansen,Pá l Weihe |
| |
| Affiliation: | The Faroese Hospital System, Tórshavn, Faroe Islands (M.S. Petersen, E.H. Eliasen, M. Johansen, A.S. Veyhe, P. Weihe);University of the Faroe Islands, Tórshavn (M.S. Petersen, M. Strøm, E.H. Eliasen, M. Johansen, A.S. Veyhe, M.F. Kristiansen, P. Weihe);Faroese Food and Veterinary Authority, Tórshavn (J.P. Fjallsbak, J.L. Hansen, S. Larsen);National Hospital of the Faroe Islands, Tórshavn (M.F. Kristiansen) |
| |
| Abstract: | We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands. |
| |
| Keywords: | COVID-19 respiratory infections severe acute respiratory syndrome coronavirus 2 SARS-CoV-2 SARS coronavirus disease zoonoses viruses coronavirus seroprevalence Faroe Islands |
|
|
